HARRISBURG, PA — Pennsylvania ranks third nationally in lung cancer screening and fourth in the share of patients receiving treatment, according to a new American Lung Association report, although the state’s lung cancer incidence remains above the national average and fewer than four in 10 eligible residents undergo screening.
The organization’s ninth annual State of Lung Cancer report found that 34.4% of Pennsylvanians at high risk for the disease received screening, compared with 24.4% nationally. Pennsylvania ranked third among 50 states evaluated for screening.
The state also recorded a five-year lung cancer survival rate of 33.4%, exceeding the national average of 31%. That placed Pennsylvania 12th among 43 states with available survival data, reflecting a 25% improvement over the past five years.
Despite those gains, Pennsylvania’s rate of new lung cancer cases remains higher than the national figure. The state recorded 55.9 new cases per 100,000 residents, compared with 52.1 nationally, ranking 30th among 51 jurisdictions evaluated.
The incidence rate has declined 10% over five years, according to the report.
Lung cancer remains the leading cause of cancer deaths in Pennsylvania and nationwide, with more than 229,000 Americans expected to receive a diagnosis this year.
The findings illustrate a divide between Pennsylvania’s comparatively strong performance in screening and treatment and the continuing burden of new diagnoses.
“Overall, our report reveals positive news—more people in the U.S. are living longer after a lung cancer diagnosis than ever before, and more people are getting screened for the disease,” said Lance Boucher, assistant vice president of state public policy for the American Lung Association.
“We need to increase screening rates among those at high risk to catch the disease early when it’s more likely to be curable and improve access to clinical trials and the best lung cancer care,” Boucher added.
Pennsylvania ranked 17th among 47 states for early diagnosis, with 30.6% of lung cancer cases detected at an early stage, compared with 29.3% nationally. The state’s early diagnosis rate has improved 19% over five years.
Early detection is particularly consequential for lung cancer because treatment is generally more effective before the disease spreads.
The report found that 22.5% of Pennsylvania lung cancer patients underwent surgery, exceeding the national rate of 21.4%. Pennsylvania ranked 11th among 40 states for surgical treatment, with its rate improving 8% over five years.
Pennsylvania performed better than most states on another treatment measure: 15.9% of lung cancer patients received no treatment, compared with 20.9% nationally.
That placed Pennsylvania fourth among 47 states for the lowest proportion of untreated cases.
The report also examined environmental and behavioral risk factors. Pennsylvania’s adult smoking rate was 11%, placing the state 28th among 48 states evaluated.
Radon exposure presented a less favorable result, with Pennsylvania ranking 39th among 51 jurisdictions on the report’s radon measure, at 39.1%.
Radon, a naturally occurring radioactive gas that can accumulate inside buildings, is the second-leading cause of lung cancer after tobacco use.
The Lung Association recommends regular residential radon testing and mitigation when elevated concentrations are detected.
Beyond screening and treatment outcomes, the report examined insurance requirements for comprehensive biomarker testing, which can identify genetic and molecular characteristics of lung tumors to guide targeted therapies and immunotherapy.
Pennsylvania requires insurance coverage of comprehensive biomarker testing, while 24 states and Washington, D.C., have no such coverage requirement, according to the report.
The organization also called for federal legislation to expand participation in cancer research, urging Congress to pass the Clinical Trial Modernization Act to address barriers that prevent patients from accessing clinical trials.
Annual low-dose computed tomography screening for people at high risk can reduce lung cancer mortality by up to 20%, according to the Lung Association.
Pennsylvania’s screening rate substantially exceeds the national average, but the findings indicate that most residents considered at high risk still are not receiving recommended screening.
The full State of Lung Cancer report is available at https://www.lung.org/solc.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.
